Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03908840
Title Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular Carcinoma
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Therapure Biopharma Inc
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.